Published in Brain on March 01, 1997
The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain (2009) 3.84
Wallerian degeneration, wld(s), and nmnat. Annu Rev Neurosci (2010) 3.22
Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol (2000) 2.99
Differential roles of microglia and monocytes in the inflamed central nervous system. J Exp Med (2014) 2.68
The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy. J Neurol (2005) 2.44
Reversal of paralysis and reduced inflammation from peripheral administration of β-amyloid in TH1 and TH17 versions of experimental autoimmune encephalomyelitis. Sci Transl Med (2012) 2.38
Progressive multiple sclerosis: pathology and pathogenesis. Nat Rev Neurol (2012) 2.32
Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J Neurosci (2009) 2.24
A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry (2001) 2.03
Radial diffusivity predicts demyelination in ex vivo multiple sclerosis spinal cords. Neuroimage (2011) 2.02
Molecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+/Ca2+ exchanger. Proc Natl Acad Sci U S A (2004) 1.99
Oxidative damage in multiple sclerosis lesions. Brain (2011) 1.95
Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? Brain (2007) 1.94
Theiler's virus infection: a model for multiple sclerosis. Clin Microbiol Rev (2004) 1.92
Mitochondrial changes within axons in multiple sclerosis. Brain (2009) 1.81
Diffusion tensor magnetic resonance imaging of Wallerian degeneration in rat spinal cord after dorsal root axotomy. J Neurosci (2009) 1.79
Neurofascin as a novel target for autoantibody-mediated axonal injury. J Exp Med (2007) 1.77
HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage. Nat Neurosci (2009) 1.67
Mechanisms of primary axonal damage in a viral model of multiple sclerosis. J Neurosci (2009) 1.65
Axonal injury in cerebral malaria. Am J Pathol (2002) 1.65
Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Prog Neurobiol (2010) 1.54
Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination. Acta Neuropathol (2012) 1.53
Retinal pathology in multiple sclerosis: insight into the mechanisms of neuronal pathology. Brain (2010) 1.45
SIRT1 activation confers neuroprotection in experimental optic neuritis. Invest Ophthalmol Vis Sci (2007) 1.41
The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage. J Neurol (2005) 1.41
Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis. PLoS One (2008) 1.39
Axonal injury heralds virus-induced demyelination. Am J Pathol (2003) 1.38
Magnetic resonance spectroscopy in the monitoring of multiple sclerosis. J Neuroimaging (2005) 1.36
Selective vulnerability of cerebral white matter in a murine model of multiple sclerosis detected using diffusion tensor imaging. Neurobiol Dis (2007) 1.33
T cell replicative senescence in human aging. Curr Pharm Des (2013) 1.31
CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis. Am J Pathol (2001) 1.28
Antigen-specific therapy promotes repair of myelin and axonal damage in established EAE. J Neurochem (2006) 1.26
Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes. Am J Pathol (2001) 1.26
Evolution of a neuroprotective function of central nervous system myelin. J Cell Biol (2006) 1.25
Activation of microglial poly(ADP-ribose)-polymerase-1 by cholesterol breakdown products during neuroinflammation: a link between demyelination and neuronal damage. J Exp Med (2003) 1.25
Animal models of multiple sclerosis: the good, the bad and the bottom line. Nat Neurosci (2012) 1.25
Review: Mitochondria and disease progression in multiple sclerosis. Neuropathol Appl Neurobiol (2008) 1.25
A combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology. Brain (2012) 1.22
Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis. J Neuroimmunol (2006) 1.16
Plasma membrane calcium ATPase deficiency causes neuronal pathology in the spinal cord: a potential mechanism for neurodegeneration in multiple sclerosis and spinal cord injury. FASEB J (2004) 1.15
Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon beta-1a (Rebif) treatment trial. J Neurol Neurosurg Psychiatry (2003) 1.15
Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis. J Neurol Neurosurg Psychiatry (1999) 1.14
Connexin43, the major gap junction protein of astrocytes, is down-regulated in inflamed white matter in an animal model of multiple sclerosis. J Neurosci Res (2005) 1.14
Clinical and neuropathologic findings in a woman with the FMR1 premutation and multiple sclerosis. Arch Neurol (2008) 1.12
Thyroid hormone administration enhances remyelination in chronic demyelinating inflammatory disease. Proc Natl Acad Sci U S A (2004) 1.12
T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS trafficking. Clin Exp Immunol (2002) 1.12
Dendritic and synaptic pathology in experimental autoimmune encephalomyelitis. Am J Pathol (2003) 1.11
Neurogenesis in the chronic lesions of multiple sclerosis. Brain (2008) 1.10
Disability outcome measures in therapeutic trials of relapsing-remitting multiple sclerosis: effects of heterogeneity of disease course in placebo cohorts. J Neurol Neurosurg Psychiatry (2000) 1.10
Chronic progressive multiple sclerosis - pathogenesis of neurodegeneration and therapeutic strategies. Curr Neuropharmacol (2010) 1.10
TASK1 modulates inflammation and neurodegeneration in autoimmune inflammation of the central nervous system. Brain (2009) 1.09
Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons. Acta Neuropathol (2013) 1.08
Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study. J Neurol Neurosurg Psychiatry (2005) 1.07
Effects of glatiramer acetate and interferon-beta on neurodegeneration in a model of multiple sclerosis: a comparative study. Am J Pathol (2006) 1.06
Axonal damage is T cell mediated and occurs concomitantly with demyelination in mice infected with a neurotropic coronavirus. J Virol (2001) 1.05
Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis. BMC Immunol (2007) 1.04
White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis. J Cereb Blood Flow Metab (2012) 1.04
GAS6 enhances repair following cuprizone-induced demyelination. PLoS One (2010) 1.03
Targeting inflammatory demyelinating lesions to sites of Wallerian degeneration. Am J Pathol (2007) 1.03
Diffusion tensor imaging in acute optic neuropathies: predictor of clinical outcomes. Arch Neurol (2011) 1.02
Quantitative ultrastructural analysis of a single spinal cord demyelinated lesion predicts total lesion load, axonal loss, and neurological dysfunction in a murine model of multiple sclerosis. Am J Pathol (2000) 1.01
Inefficient clearance of myelin debris by microglia impairs remyelinating processes. J Exp Med (2015) 1.01
Loss of translation elongation factor (eEF1A2) expression in vivo differentiates between Wallerian degeneration and dying-back neuronal pathology. J Anat (2008) 1.01
Progressive multiple sclerosis. Semin Immunopathol (2009) 1.00
The immunopathophysiology of multiple sclerosis. Neurol Clin (2011) 0.99
Visual recovery following acute optic neuritis--a clinical, electrophysiological and magnetic resonance imaging study. J Neurol (2004) 0.99
Involvement of tissue plasminogen activator in onset and effector phases of experimental allergic encephalomyelitis. J Neurosci (2002) 0.98
Axonal protection achieved in a model of multiple sclerosis using lamotrigine. J Neurol (2006) 0.98
Phosphorylation and compactness of neurofilaments in multiple sclerosis: indicators of axonal pathology. Exp Neurol (2008) 0.98
The pathology of multiple sclerosis and its evolution. Philos Trans R Soc Lond B Biol Sci (1999) 0.97
Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis. J Neurol Neurosurg Psychiatry (2002) 0.96
NG2-expressing cells in the nervous system: role of the proteoglycan in migration and glial-neuron interaction. J Anat (2005) 0.96
TREM2 regulates microglial cell activation in response to demyelination in vivo. Acta Neuropathol (2015) 0.95
Diffusion tensor imaging of the optic tracts in multiple sclerosis: association with retinal thinning and visual disability. J Neuroimaging (2011) 0.95
Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance. Philos Trans R Soc Lond B Biol Sci (1999) 0.94
Demyelination and axonal preservation in a transgenic mouse model of Pelizaeus-Merzbacher disease. EMBO Mol Med (2010) 0.94
Extensive acute axonal damage in pediatric multiple sclerosis lesions. Ann Neurol (2015) 0.94
Myelin repair: the role of stem and precursor cells in multiple sclerosis. Philos Trans R Soc Lond B Biol Sci (2008) 0.93
Mechanisms of normal appearing corpus callosum injury related to pericallosal T1 lesions in multiple sclerosis using directional diffusion tensor and 1H MRS imaging. J Neurol Neurosurg Psychiatry (2004) 0.93
Reduced expression of plasma membrane calcium ATPase 2 and collapsin response mediator protein 1 promotes death of spinal cord neurons. Cell Death Differ (2010) 0.93
Recent neuropathological findings in MS--implications for diagnosis and therapy. J Neurol (2004) 0.93
Prevention of axonal injury using calpain inhibitor in chronic progressive experimental autoimmune encephalomyelitis. Brain Res (2008) 0.92
Contrasting roles for axonal degeneration in an autoimmune versus viral model of multiple sclerosis: When can axonal injury be beneficial? Am J Pathol (2007) 0.92
MR spectroscopy of cervical spinal cord in patients with multiple sclerosis. Neuroradiology (2004) 0.92
Myelin loss does not lead to axonal degeneration in a long-lived model of chronic demyelination. J Neurosci (2013) 0.92
Axonal degeneration as a therapeutic target in the CNS. Cell Tissue Res (2012) 0.91
Neural Plasticity in Multiple Sclerosis: The Functional and Molecular Background. Neural Plast (2015) 0.91
Promoting remyelination in multiple sclerosis-recent advances. Drugs (2013) 0.91
CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies. Br J Pharmacol (2007) 0.91
Theiler's virus infection: Pathophysiology of demyelination and neurodegeneration. Pathophysiology (2011) 0.91
A mechanism of virus-induced demyelination. Interdiscip Perspect Infect Dis (2010) 0.90
Abnormal Purkinje cell activity in vivo in experimental allergic encephalomyelitis. Exp Brain Res (2004) 0.90
Axon damage and repair in multiple sclerosis. Philos Trans R Soc Lond B Biol Sci (1999) 0.90
Axonal degeneration as a self-destructive defense mechanism against neurotropic virus infection. Future Virol (2008) 0.90
Regulated release of BDNF by cortical oligodendrocytes is mediated through metabotropic glutamate receptors and the PLC pathway. ASN Neuro (2009) 0.90
Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis. J Neurol (2011) 0.90
Axonal pathology precedes demyelination in a mouse model of X-linked demyelinating/type I Charcot-Marie Tooth neuropathy. J Neuropathol Exp Neurol (2010) 0.89
Temporal pattern of plasma membrane calcium ATPase 2 expression in the spinal cord correlates with the course of clinical symptoms in two rodent models of autoimmune encephalomyelitis. Eur J Neurosci (2005) 0.89
Increased expression of ICAM-1, VCAM-1, MCP-1, and MIP-1 alpha by spinal perivascular macrophages during experimental allergic encephalomyelitis in rats. BMC Immunol (2002) 0.89
Autoantibodies to Non-myelin Antigens as Contributors to the Pathogenesis of Multiple Sclerosis. J Clin Cell Immunol (2013) 0.89
Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc Natl Acad Sci U S A (1985) 4.97
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience (1990) 4.52
Plaques, tangles and dementia. A quantitative study. J Neurol Sci (1982) 4.52
Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat Neurosci (2001) 4.10
Systemic inflammation and disease progression in Alzheimer disease. Neurology (2009) 3.79
Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain. Neuroscience (1985) 3.27
Absence of Wallerian Degeneration does not Hinder Regeneration in Peripheral Nerve. Eur J Neurosci (1989) 3.24
Hippocampal specialization of food-storing birds. Proc Natl Acad Sci U S A (1989) 2.84
Turnover of resident microglia in the normal adult mouse brain. Neuroscience (1992) 2.73
A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse. Proc Natl Acad Sci U S A (2000) 2.40
Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol (2000) 2.37
Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology. Neuropathol Appl Neurobiol (2008) 2.32
Macrophages and microglia in the nervous system. Trends Neurosci (1988) 2.32
Retinal ganglion cells that project to the dorsal lateral geniculate nucleus in the macaque monkey. Neuroscience (1984) 2.30
Axonal damage: a key predictor of outcome in human CNS diseases. Brain (2003) 2.27
Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J Neurol Sci (1982) 2.17
Neuropathologic evidence of endothelial changes in cerebral small vessel disease. Neurology (2011) 2.15
Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet (1999) 2.11
Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology (2006) 2.10
Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease. Eur J Neurosci (2003) 2.07
Herpes simplex encephalitis. An immunohistological study of the distribution of viral antigen within the brain. J Neurol Sci (1982) 2.02
The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. J Neurol Sci (1989) 1.95
Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo. Neuroscience (1998) 1.94
Lymphocyte proliferation to artery antigen as a positive diagnostic test in polymyalgia rheumatica. Ann Rheum Dis (1975) 1.94
The mononuclear phagocyte system of the mouse defined by immunohistochemical localisation of antigen F4/80: macrophages associated with epithelia. Anat Rec (1984) 1.91
Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease. Neuroscience (2002) 1.90
Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2003) 1.84
Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol (1997) 1.84
Immunohistochemical localization of a macrophage-specific antigen in developing mouse retina: phagocytosis of dying neurons and differentiation of microglial cells to form a regular array in the plexiform layers. J Cell Biol (1983) 1.80
Review: activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol (2013) 1.77
The effect of non-steroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: Implications for a role of COX-1. Brain Behav Immun (2009) 1.76
Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. Dementia (1995) 1.76
Herpes Zoster. Demonstration of virus in trigeminal nerve and ganglion by immunofluorescence and electron microscopy. J Neurol Sci (1972) 1.76
The macrophage response to central and peripheral nerve injury. A possible role for macrophages in regeneration. J Exp Med (1987) 1.75
The cortex of the primary auditory area in Alzheimer's disease. Brain Res (1986) 1.71
The olfactory bulbs in Alzheimer's disease. J Neurol Neurosurg Psychiatry (1984) 1.71
Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin. Science (1997) 1.70
Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology. J Neurol Neurosurg Psychiatry (2001) 1.70
Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord. Eur J Neurosci (1999) 1.68
Altered antigen expression of microglia in the aged rodent CNS. Glia (1993) 1.68
The ganglion cell and cone distributions in the monkey's retina: implications for central magnification factors. Vision Res (1985) 1.66
The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C). Brain Behav Immun (2007) 1.65
Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts. Brain (2004) 1.63
Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer's disease prospectively assessed for behavioural changes. Neuropathol Appl Neurobiol (2000) 1.63
Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain (2000) 1.62
Systemic infection and inflammation in acute CNS injury and chronic neurodegeneration: underlying mechanisms. Neuroscience (2008) 1.61
An 85-kb tandem triplication in the slow Wallerian degeneration (Wlds) mouse. Proc Natl Acad Sci U S A (1998) 1.61
Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol (2000) 1.60
Monoclonal antibody to macrophages (EMB/11) labels macrophages and microglial cells in human brain. J Clin Pathol (1986) 1.60
Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain (2001) 1.60
Mechanisms to explain the reverse perivascular transport of solutes out of the brain. J Theor Biol (2005) 1.59
White matter damage is associated with matrix metalloproteinases in vascular dementia. Stroke (2001) 1.59
Interleukin-1beta -induced changes in blood-brain barrier permeability, apparent diffusion coefficient, and cerebral blood volume in the rat brain: a magnetic resonance study. J Neurosci (2000) 1.59
Evidence for an amacrine cell system in the ganglion cell layer of the rat retina. Neuroscience (1981) 1.58
Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions. Acta Neuropathol (1997) 1.58
Synaptic pathology in prefrontal cortex is present only with severe dementia in Alzheimer disease. J Neuropathol Exp Neurol (2001) 1.56
Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin. Proc Natl Acad Sci U S A (1999) 1.53
Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J Neurol Sci (1983) 1.53
Tumor necrosis factor mRNA localized to Paneth cells of normal murine intestinal epithelium by in situ hybridization. J Exp Med (1990) 1.52
The effects of additional pathology on the cognitive deficit in Alzheimer disease. J Neuropathol Exp Neurol (1997) 1.52
Postnatal changes in retinal ganglion cell and optic axon populations in the pigmented rat. J Comp Neurol (1983) 1.51
Evidence for dendritic competition in the developing retina. Nature (1982) 1.50
Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neuroscience (1995) 1.48
Proinflammatory cytokines, sickness behavior, and Alzheimer disease. Neurology (2011) 1.48
Anomalous asymmetry of fusiform and parahippocampal gyrus gray matter in schizophrenia: A postmortem study. Am J Psychiatry (2000) 1.48
The size and fibre composition of the corpus callosum with respect to gender and schizophrenia: a post-mortem study. Brain (1999) 1.47
Antigen markers of macrophage differentiation in murine tissues. Curr Top Microbiol Immunol (1992) 1.47
Early behavioural changes in scrapie-affected mice and the influence of dapsone. Eur J Neurosci (2001) 1.47
The contribution of demyelination to axonal loss in multiple sclerosis. Brain (2006) 1.46
The extent of axonal loss in the long tracts in hereditary spastic paraplegia. Neuropathol Appl Neurobiol (2004) 1.46
Human and viral gene detection in routine paraffin embedded tissue by in situ hybridisation with biotinylated probes: viral localisation in herpes encephalitis. J Clin Pathol (1986) 1.45
Multiple sclerosis with clinical and radiological features of cerebral tumour. J Neurol Neurosurg Psychiatry (1982) 1.45
Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain (1987) 1.44
The ganglion cell layer of the retina of the rat: a Golgi study. Proc R Soc Lond B Biol Sci (1979) 1.42
CXC chemokines generate age-related increases in neutrophil-mediated brain inflammation and blood-brain barrier breakdown. Curr Biol (1998) 1.41
The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system. Neuroscience (1996) 1.41
Lymphocyte sensitivity to skeletal muscle in patients with polymyositis and other disorders. Clin Exp Immunol (1973) 1.41
Intrasellar gangliocytoma containing gastrin and growth hormone-releasing hormone associated with a growth hormone-secreting pituitary adenoma. Clin Endocrinol (Oxf) (1989) 1.41
Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Neuropathol Appl Neurobiol (1997) 1.39
Evidence for an early inflammatory response in the central nervous system of mice with scrapie. Neuroscience (1996) 1.38
Rapidly progressing atrophy of medial temporal lobe in Alzheimer's disease. Lancet (1994) 1.38
Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. Brain (1997) 1.37
Cerebral amyloid angiopathy in dementia and old age. J Neurol Neurosurg Psychiatry (1986) 1.37
Overriding the brain's intrinsic resistance to leukocyte recruitment with intraparenchymal injections of recombinant chemokines. Neuroscience (1996) 1.36
Sub-pyrogenic systemic inflammation impacts on brain and behavior, independent of cytokines. Brain Behav Immun (2007) 1.34
Immunoglobulin-containing cells in multiple-sclerosis plaques. Lancet (1977) 1.33
Massive retinotectal projection in rats. Brain Res (1983) 1.32
Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase. Brain Res (1983) 1.29
Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease. J Neurochem (1983) 1.28
Neuropathologically distinct prion strains give rise to similar temporal profiles of behavioral deficits. Neurobiol Dis (2005) 1.28
Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation. Blood (2001) 1.28
The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience (1992) 1.28
Macrophage dependence of peripheral sensory nerve regeneration: possible involvement of nerve growth factor. Neuron (1991) 1.27
Multiple sclerosis: a quantitative and qualitative study of immunoglobulin-containing cells in the central nervous system. Neuropathol Appl Neurobiol (1980) 1.26
The kinetics and morphological characteristics of the macrophage-microglial response to kainic acid-induced neuronal degeneration. Neuroscience (1991) 1.24
The nucleus basalis in Alzheimer's disease: cell counts and cortical biochemistry. Neuropathol Appl Neurobiol (1983) 1.24
Inflammation in the nervous system. Curr Opin Neurobiol (1995) 1.24
Retinal ganglion cells that project to the superior colliculus and pretectum in the macaque monkey. Neuroscience (1984) 1.24